1. Home
  2. WVE vs ALGT Comparison

WVE vs ALGT Comparison

Compare WVE & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • ALGT
  • Stock Information
  • Founded
  • WVE 2012
  • ALGT 1997
  • Country
  • WVE Singapore
  • ALGT United States
  • Employees
  • WVE N/A
  • ALGT N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • ALGT Air Freight/Delivery Services
  • Sector
  • WVE Health Care
  • ALGT Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • ALGT Nasdaq
  • Market Cap
  • WVE 915.6M
  • ALGT 750.0M
  • IPO Year
  • WVE 2015
  • ALGT 2006
  • Fundamental
  • Price
  • WVE $9.76
  • ALGT $59.78
  • Analyst Decision
  • WVE Strong Buy
  • ALGT Hold
  • Analyst Count
  • WVE 16
  • ALGT 9
  • Target Price
  • WVE $20.00
  • ALGT $66.56
  • AVG Volume (30 Days)
  • WVE 1.6M
  • ALGT 501.9K
  • Earning Date
  • WVE 07-30-2025
  • ALGT 08-04-2025
  • Dividend Yield
  • WVE N/A
  • ALGT N/A
  • EPS Growth
  • WVE N/A
  • ALGT N/A
  • EPS
  • WVE N/A
  • ALGT N/A
  • Revenue
  • WVE $93,946,000.00
  • ALGT $2,578,359,000.00
  • Revenue This Year
  • WVE N/A
  • ALGT $6.82
  • Revenue Next Year
  • WVE $4.55
  • ALGT $10.84
  • P/E Ratio
  • WVE N/A
  • ALGT N/A
  • Revenue Growth
  • WVE N/A
  • ALGT 3.17
  • 52 Week Low
  • WVE $5.04
  • ALGT $37.50
  • 52 Week High
  • WVE $16.74
  • ALGT $107.57
  • Technical
  • Relative Strength Index (RSI)
  • WVE 72.03
  • ALGT 64.44
  • Support Level
  • WVE $8.40
  • ALGT $47.83
  • Resistance Level
  • WVE $9.03
  • ALGT $61.83
  • Average True Range (ATR)
  • WVE 0.55
  • ALGT 3.15
  • MACD
  • WVE 0.06
  • ALGT 1.36
  • Stochastic Oscillator
  • WVE 98.53
  • ALGT 89.36

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.

Share on Social Networks: